ArticleMolecular medicine (Cambridge, Mass.)2025

TMSB10 drives prostate cancer aggressiveness via immune microenvironment regulation.

Haoran Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.